Drugs / Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00985153 | Mar 2000 → May 2001 | chickenpox, measles, mumps infectious disease, rubella | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00985153 ↗ |
| Known as | MMRV | “Study participants 12 to 23 months of age received a single injection of either one of 3 consistency lots of MMRV or MMR + V administered at separate injection sites.” PMID 16804432 ↗ Jul 2006 |
| Modality | Vaccine | “a combined measles, mumps, rubella and varicella vaccine (MMRV)” PMID 16804432 ↗ Jul 2006 |
| Route | Subcutaneous | “A Single 0.5 mL subcutaneous injection at Day 0” NCT00985153 ↗ |